Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deterioratingPRNewsWire • 10/31/24
Volition to share new 'NETs in sepsis management' data insights at upcoming webinarPRNewsWire • 10/09/24
VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business UpdatePRNewsWire • 08/14/24
VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business UpdatePRNewsWire • 08/06/24
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensingPRNewsWire • 07/09/24
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire • 06/14/24
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business UpdatePRNewsWire • 05/13/24
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business UpdatePRNewsWire • 05/08/24
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business UpdatePRNewsWire • 03/25/24
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business UpdatePRNewsWire • 03/21/24